6 results match your criteria: "Nuestra Señora de Valme Hospital[Affiliation]"
Gender Differences in Outcomes of Ambulatory and Hospitalized Patients With Obesity Hypoventilation Syndrome.
Chest
October 2024
Instituto Universitario de Investigación Biosanitaria de Extremadura, Badajoz, Spain; CIBER de Enfermedades Respiratorias (CIBERES), Madrid, Spain; Respiratory Department, Virgen del Puerto Hospital, Plasencia, Cáceres, Spain.
Article Synopsis
- Obesity hypoventilation syndrome (OHS) has high health risks, and this study looks into whether gender affects outcomes for patients with OHS, focusing on both outpatient and hospitalized cases.
- The research analyzed two groups: stable ambulatory patients and hospitalized patients with respiratory failure, assessing gender differences through various statistical methods.
- Findings indicate that while women were generally older and more obese, gender alone did not significantly influence emergency room visits or mortality rates after adjustments for factors like age and obesity.
How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain.
HIV Med
February 2020
National Epidemiology Centre, Carlos III Health Institute, Madrid, Spain.
Objectives: The aim of this study was to evaluate adherence to the recommendations of the Spanish guidelines for the initial assessment of patients with HIV infection in the multicentre Cohort of the Spanish HIV/AIDS Network (CoRIS) during the years 2004-2017.
Methods: We calculated the percentage of patients who had each of 11 clinical and analytical recommended examinations performed in their initial evaluation. We evaluated the factors associated with not performing each examination with multivariable logistic regression models.
Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group.
Eur J Cancer
April 2017
Maimonides Institute of Biomedical Research (IMIBIC), Reina Sofía Hospital, University of Córdoba, Spanish Cancer Network (RTICC), Instituto de Salud Carlos III, Córdoba, Spain.
Background: Gemcitabine and erlotinib have shown a survival benefit in the first-line setting in metastatic pancreatic cancer (mPC). The aim of this study was to assess whether combining capecitabine (C) with gemcitabine + erlotinib (GE) was safe and effective versus GE in patients with mPC.
Patients And Methods: Previously untreated mPC patients were randomised to receive G (1000 mg/m, days 1, 8, 15) + E (100 mg/day, days 1-28) + C (1660 mg/m, days 1-21) or GE, q4 weeks, until progression or unacceptable toxicity.
Design and validation of a predictive model for 1-year hospital admission in HIV patients on antiretroviral treatment.
Eur J Hosp Pharm
July 2016
Pharmacy Department, Nuestra Señora de Valme Hospital, Seville, Spain.
Objectives: To develop and validate a model for predicting the risk of hospital admission within 1 year in the HIV population under antiretroviral treatment.
Methods: We conducted a retrospective observational study. Patients receiving antiretroviral treatment for at least 1 year who were followed by the pharmacy service in a Spanish-speaking hospital between January 2008 and December 2012 were included.
Prevalence and appropriateness of procedures for altering oral dosage forms in a cohort of elderly institutionalized patients.
Geriatr Gerontol Int
March 2016
Pharmacy Department, Ferrol Health District, Ferrol, Spain.
Influence of treatment complexity on adherence and incidence of blips in HIV/HCV coinfected patients.
J Manag Care Spec Pharm
February 2015
Nuestra Señora de Valme Hospital, Av. Bellavista, s/n, 41014. Seville, Spain.
Background: The addition of antihepatitis C therapy to highly active antiretroviral treatment (HAART) in human immunodeficiency virus (HIV)/hepatitis C virus (HCV) coinfected patients leads to an increase in the treatment complexity that may result in decreased adherence. Blips, defined as intermittent episodes of detectable low-level HIV viremia, may be an indication of poor adherence to HAART.
Objectives: To (a) determine the influence of adding anti-HCV therapy to HAART on complexity index, adherence, and incidence of blips and (b) determine complexity index and adherence in patient subgroups based on anti-HCV therapy.